Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

Oregon Health and Science University, Knight Cancer Institute Portland, Oregon Telepharmacy: The Future Is Now OHSU Knight Cancer Institute developed remote medication verification technology that reduced risk, improved safety, and saved about $450,000 in yearly personnel expenses.
UMC Health System, Southwest Cancer Center Lubbock, Texas Process Improvement Through Patient and Employee Feedback This community cancer program develops tools that give voice to patients and empower staff to consistently improve the overall patient experience.. Read Article
Kashyap Patel, MD, is a board certified hematologist/oncologist who specializes in palliative care. He is a full-time practicing medical oncologist with more than 20 years of experience working directly with cancer patients. Dr. Patel serves as President of the Community Oncology Alliance, on the advisory board for Medicaid HMOs, and has been a Carrier Advisory Committee member for the DHHS (SC), Palmetto …
Timothy D. Gauntner, DO, PhD, et al., Internal Medicine Resident at the University of Minnesota, Minneapolis, MN View Poster
Krista Nelson, ACCC President 2021-22, shares self-care resources for cancer team members during the COVID-19 outbreak and guides us through a brief mindfulness exercise.
Learn how some cancer programs are finding creative ways to engage patients and adapt screening programs during these difficult times.
Presented at the IASCLC 2020 North America Conference on Lung Cancer.
If biomarker testing shows that you are positive for a certain biomarker (positive means you have it), your doctor can choose treatments that work to attack the specific biomarker you have.
Disclosures and Conflict of Interest (COI) Mitigation Faculty, Staff, and Planners’ Disclosures The following individuals have no relevant financial relationships with ineligible companies to disclose: Simon Fung-Kee-Fung, Ruth O’Regan, MD; Rahul Seth, DO; Tracey O’Connor, MD, and the staffs of the Empire State Hematology and Oncology Society and Physicians’ Education Resource®, LLC. Faculty …
Fall 2023 Speaker Presentations Final Medicare Physician Fee Schedule and Hospital Outpatient Prospective Pay System Rules and and Policy Update Presenters: Teri Bedard, BA, RT (R)(T)(ARRT), CPC, Executive Director of Client and Corporate Resources, Revenue Cycle Coding Strategies Nicole Tapay, JD, Director of Cancer Care Delivery and Health Policy, ACCC Coding and Billing for Chronic …
10 Steps to Success: Integrating Oral Oncolytics into Chronic Lymphocytic Leukemia (CLL) Practice EFFECTIVE PRACTICE GUIDE Oral Oncolytic Clinical Workflow for Treatment of Patients with Chronic Lymphocytic Leukemia OTC = over the counter, Rx=prescription, ACCC FAN = Association of Community Cancer Centers Financial Advocacy Network), EMR=Electronic Medical Record Clinical …
10 Steps to Success: Integrating Oral Oncolytics into Chronic Lymphocytic Leukemia (CLL) Practice EFFECTIVE PRACTICE GUIDE Oral Oncolytic Clinical Workflow for Treatment of Patients with Chronic Lymphocytic Leukemia OTC = over the counter, Rx=prescription, ACCC FAN = Association of Community Cancer Centers Financial Advocacy Network), EMR=Electronic Medical Record Clinical …
Social drivers of health (SDOH) refer to the conditions in which people live, work, and play. SDOH are defined as external factors including social, economic, and educational factors as well as infrastructure and healthcare.
DATE & TIME EVENT VENUE targetedonc.com/events Register Today In-person seating is limited to 14 participants. Interested in joining the discussion? Join Targeted Oncology™ for a collaborative, small- group meeting designed around case-based clinical profiles and peer led by an expert physician. This session offers practicing oncologists the perfect opportunity to sharpen their …
Disclosures and Conflict of Interest (COI) Mitigation Faculty, Staff, and Planners’ Disclosures The following individuals have no relevant financial relationships with ineligible companies to disclose: Stephen Edge, MD, Carla Falkson, MBChB., M.Med., MD, Kimberly R. Gergelis, MD, Alissa Huston, MD, Sheheryar Kabraji, BMBCh, the staffs of the Empire State Hematology and Oncology Society and …
Featured in Oncology Issues e-Consults for Immune-Related Toxicities Improve Patient Access and Reduce Costs Presently at Duke Cancer Institute, for patients with cancer, the average wait time to see an endocrine specialist is 87 days. One solution to this challenge is to implement expert triage from an endocrinologist who can review the case via an e-communication based platform. This platform can …
PowerPoint Presentation Advancements in Gastrointestinal Health – A Comprehensive Update Anahat Kaur, MD Hematology and Medical Oncology Charleston Area Medical Center, WV • SKYSCRAPER - 08: Phase III study of first-line tiragolumab + atezolizumab and chemotherapy in patients with advanced esophageal SCC Esophageal Squamous Cell Carcinoma • GLOW: Zolbetuximab + CAPOX …
Multiple Myeloma: Challenging Cases of Relapsed/ Refractory Multiple Myeloma MODERATOR Dr. Laura Finn Ochsner Health targetedonc.com/events Register Today In this discussion, we will review two case studies to foster discussion of how we care for patients with relapsed refractory Multiple Myeloma. One case will focus on the early relapse setting and one will focus on later lines …
Multiple Myeloma: Challenging Cases of Relapsed/ Refractory Multiple Myeloma MODERATOR Dr. Morie Gertz Mayo Clinic targetedonc.com/events Register Today In this discussion, we will review two case studies to foster discussion of how we care for patients with relapsed refractory Multiple Myeloma. One case will focus on the early relapse setting and one will focus on later lines of …